SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001367644-11-000017
Filing Date
2011-03-11
Accepted
2011-03-10 18:49:24
Documents
11
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k_2010.htm 10-K 2411113
2 exhibit21_1.htm EX-21.1 13646
3 exhibit23_1.htm EX-23.1 7496
4 exhibit31_1.htm EX-31.1 9405
5 exhibit31_2.htm EX-31.2 10448
6 exhibit32_1.htm EX-32.1 4455
7 exhibit32_2.htm EX-32.2 5502
8 exhibit10_49.htm EX-10.49 198513
9 exhibit10_50.htm EX-10.50 771
10 exhibit10-502.jpg GRAPHIC 156918
11 exhibit10-503.jpg GRAPHIC 44689
  Complete submission text file 0001367644-11-000017.txt   2940379
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33137 | Film No.: 11679841
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences